Matches in Wikidata for { <http://www.wikidata.org/entity/Q62025154> ?p ?o ?g. }
Showing items 1 to 42 of
42
with 100 items per page.
- Q62025154 description "clinical trial" @default.
- Q62025154 description "ensayo clínico" @default.
- Q62025154 description "ensayu clínicu" @default.
- Q62025154 description "klinisch onderzoek" @default.
- Q62025154 description "клінічне випробування" @default.
- Q62025154 description "临床试验" @default.
- Q62025154 name "First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System Metastases" @default.
- Q62025154 type Item @default.
- Q62025154 label "First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System Metastases" @default.
- Q62025154 prefLabel "First Line Treatment in EGFR Mutation Positive Advanced NSCLC Patients With Central Nervous System Metastases" @default.
- Q62025154 P1132 Q62025154-3EDA8B98-6811-4F20-9803-AF4D151678DE @default.
- Q62025154 P1476 Q62025154-EE849EF4-08FD-4576-A67D-DC47EF8A44B8 @default.
- Q62025154 P17 Q62025154-4C34CB0D-1C55-40A4-8DF0-95E9796952C0 @default.
- Q62025154 P17 Q62025154-58EC2242-9BA8-4BDD-BB00-7CADD8DFD646 @default.
- Q62025154 P1813 Q62025154-1A4A12E1-F767-4A8C-8678-2E030B6B1386 @default.
- Q62025154 P2899 Q62025154-FAE0A632-6E04-45B1-9F9F-CC9D04CCB65B @default.
- Q62025154 P3098 Q62025154-519D2FEC-B725-47AF-89B8-30D8211D71B6 @default.
- Q62025154 P31 Q62025154-EEA7D900-C615-4B0C-BCB7-88446EAE45F8 @default.
- Q62025154 P4844 Q62025154-298493BB-0940-49E1-AC20-A62804DB6B31 @default.
- Q62025154 P4844 Q62025154-DF5473AC-4BE2-4F81-ACB4-1BC82544F931 @default.
- Q62025154 P580 Q62025154-3A50A904-6741-41F2-916B-C643AC7E91A7 @default.
- Q62025154 P582 Q62025154-308D5AC9-130B-4CEA-AAAB-EF6E38B913A4 @default.
- Q62025154 P6099 Q62025154-2B0D03DA-3545-448A-958B-33A82D09DD0D @default.
- Q62025154 P6099 Q62025154-8D88CE23-4478-4718-B13A-D429CB799579 @default.
- Q62025154 P8005 Q62025154-CF6352CF-0800-4B9C-972B-36F2024A84DE @default.
- Q62025154 P8363 Q62025154-77B79A54-0408-4134-8FAC-ABC0062D3162 @default.
- Q62025154 P1132 "+300" @default.
- Q62025154 P1476 "A Randomized, Open-label, Controlled, Multi-Center Phase II/III Study to Assess the Efficacy and Safety of AZD3759 vs. a Standard of Care EGFR TKI, as First Line Treatment to EGFR Mutation Positive Advanced NSCLC With CNS Metastases" @default.
- Q62025154 P17 Q334 @default.
- Q62025154 P17 Q865 @default.
- Q62025154 P1813 "BM" @default.
- Q62025154 P2899 "+18" @default.
- Q62025154 P3098 "NCT03653546" @default.
- Q62025154 P31 Q30612 @default.
- Q62025154 P4844 Q27124083 @default.
- Q62025154 P4844 Q417824 @default.
- Q62025154 P580 "2018-10-29T00:00:00Z" @default.
- Q62025154 P582 "2021-06-15T00:00:00Z" @default.
- Q62025154 P6099 Q42824440 @default.
- Q62025154 P6099 Q42824827 @default.
- Q62025154 P8005 Q76649708 @default.
- Q62025154 P8363 Q78089383 @default.